Pandora Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.07M Sell
19,800
-100
-0.5% -$4.81K 0.65% 28
2025
Q3
$897K Hold
19,900
0.54% 33
2025
Q2
$921K Hold
19,900
0.57% 33
2025
Q1
$1.21M Buy
+19,900
New +$1.16M 0.8% 27

Other funds holding BMY

Pandora Wealth's BMY Position: Q4 2025 in Review

Pandora Wealth reduced its Bristol-Myers Squibb (BMY) stake by 0.5% in Q4 2025, selling an estimated $4.81K and leaving 19,800 shares worth $1.07M. The position accounts for 0.65% of the portfolio, ranked #28.

Pandora Wealth first reported a position in BMY in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.21M in Q1 2025. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Pandora Wealth held 19,800 shares of Bristol-Myers Squibb worth $1.07M as of Q4 2025.
  • Pandora Wealth sold 100 Bristol-Myers Squibb shares in Q4 2025, an estimated $4.81K.
  • Bristol-Myers Squibb made up 0.65% of Pandora Wealth's portfolio in Q4 2025, its #28 holding.
  • Pandora Wealth first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 4 quarters since.
  • Pandora Wealth's Bristol-Myers Squibb position peaked at $1.21M in Q1 2025.
  • 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Pandora Wealth's 13F filing for Q4 2025, filed 4 Feb 2026.